Effect of in vivo administration of interferon gamma on expression of MHC products and tumour associated antigens in patients with metastatic melanoma

This publication has 22 references indexed in Scilit:

• Interferon-Induced Changes in Pharmacokinetics and Tumor Uptake of 111In-Labeled Antimelanoma Antibody 96.5 in Melanoma Patients
  JNCI Journal of the National Cancer Institute, 1988
• Recombinant Interferon Enhances Monoclonal Antibody-Targeting of Carcinoma Lesions in Vivo
  Science, 1987
• Interferon gamma regulates HLA-D expression on solid tumors in vivo
  European Journal of Cancer and Clinical Oncology, 1986
• Antigenic Characteristics of Glycosylated Natural and Unglycosylated Recombinant Human Gamma-Interferon
  Journal of Interferon Research, 1986
• Structural studies on acid unfolding and refolding of recombinant human interferon .gamma.
  Biochemistry, 1985
• Analysis of antibody response in patients receiving recombinant Escherichia coli-derived human interferon-gamma
  Clinical Immunology and Immunopathology, 1985
• Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens
  European Journal of Immunology, 1985
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
  The Journal of Experimental Medicine, 1983
• Monitoring of Interferon Therapy by Assay of (2′-5′) Oligo-Isoadenylate Synthetase in Human Peripheral White Blood Cells
  Journal of Interferon Research, 1981